Eur Neuropsychopharmacol
From Bioblast
Revision as of 16:44, 27 March 2018 by Kandolf Georg (talk | contribs) (Created page with "{{Journal |Title=[https://www.journals.elsevier.com/european-neuropsychopharmacology/ European Neuropsychopharmacology] }}")
| Journal title and website | European Neuropsychopharmacology |
|---|
Publications
| Reference | Published | View | |
|---|---|---|---|
| Bespalov 2019 Eur Neuropsychopharmacol | Bespalov A, Steckler T, Skolnick P (2019) Be positive about negatives-recommendations for the publication of negative (or null) results. Eur Neuropsychopharmacol 29(12): 1312-1320. | 2019 | PMID:31753777 Open Access |
| Scaini 2018 Eur Neuropsychopharmacol | Scaini G, Quevedo J, Velligan D, Roberts DL, Raventos H, Walss-Bass C (2018) Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia. Eur Neuropsychopharmacol 28:369-80. | 2018 | PMID: 29449054 |
